Boehringer backs Brainomix AI software for lung fibrosis

Boehringer backs Brainomix AI software for lung fibrosis

Source: 
Pharmaphorum
snippet: 

Boehringer Ingelheim has joined forces with digital health firm Brainomix on a project to improve the care of people with fibrosing lung diseases in the US.